Champions Oncology to Announce First Quarter Financial Results on Friday, September 13

Hackensack, NJ – September 9, 2013 – Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that it will announce its financial and operational results for the first quarter ended July 31, 2013 on Friday, September 13.

In connection, the Company will host a conference call to discuss results the same day at 8:30am ET. To participate in the call, please call 800-875-3456 (domestic), 800-648-0973 (Canadian Toll Free) or 302-607-2001 (international) ten minutes ahead of the call and give the verbal passcode “Champions Oncology”.

An MP3 recoding of the call will be available on the Investor tab of the Company’s website within 72 hours.

Champions Oncology - Specializing in | Personalized Cancer Therapy | Translational Oncology Solutions | Oncology drug development | Oncology drug discovery | Translational oncology | Translation oncology research | Predictive oncology | Patient-derived xenograft model | Tumorgrafts | Alternative/new cancer treatment | Anticancer therapies | Personalized cancer treatment | Personalized cancer therapy | Personalized oncology